|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pretreatment cytogenetic abnormalities are predictive of induction success,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia:results from Cancer and Leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mr6zek K Dodge RK | 2002 | {H}Blood2002，，13： | 1 |
| 2 | Pretreatment cytogenetic abnormalities are predictive of induction success,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia:Results from Cancer and Leukemia Group B(CALGB8461)显示文摘 | Byrd JC Mrózek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 3 | Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer显示文摘 | Pence JC Kerns BJ Dodge RK | 1993 | Arch Surg1993，128，12： | 1 |
| 4 | Pretreatment cy- togenetic abnormalities are predictive of induction suc- cess,cumulative incidence of relapse, and overall sur- vival in adult patients with de novo acute myeloid leu- kemia~ results from Cancer and Leukemia Group B (CALGB 8461) 显示文摘 | Byrd JC Mr6zek K Dodge RK | 2002 | Blood2002，100，： | 1 |
| 5 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group S (CALGB 8461) 显示文摘 | Byrd JC Mrozek K Dodge RK | 2002 | Blood2002，，： | 1 |
| 6 | Pretreatment cytogenetic abnormalities arc predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia;results from Cancer and Leukemia Group B (CALGB8461) 显示文摘 | Byrd JC Mrozek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 7 | AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice显示文摘 | Dodge JC Treleaven CM Fidler JA | 2010 | Mol Ther2010，18，12： | 1 |
| 8 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mrozek K Dodge RK | 2002 | Blood2002，100，： | 1 |
| 9 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia group B (CALGB 8461)显示文摘 | BYRD JC MROZEK K DODGE RK | 2002 | Blood2002，100，： | 1 |
| 10 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia results from Cancer and Leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mrozek K Dodge RK | 2002 | Blood2002，100，： | 1 |
| 11 | Pretreatment cytogenetic abnormalities are predictive of induction SUCCESS,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid Ieukemia:results from Cancer and Leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mr(O)zek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 12 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative inci- dence of relapse,and overall survival in adult patients with de no- vo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) 显示文摘 | Byrd JC Mrbzek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 13 | Pretreatment cytogenetic abnormalities are predictive of induction success,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia:results from Cancer and leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mr6zek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 14 | Pretreatment cytogenetic abnormalities are Predictive of induction success,cumulative incidence of relapse,and over all survival in adult patients with de novo acute myeloid leukemia :results from Cancer and Leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mr zek K Dodge RK | 2002 | Blood2002，100，： | 1 |
| 15 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461) 显示文摘 | Byrd JC Mrozek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 16 | Patients with t ( 8 ;21 ) ( q22 ; q22 ) and acute myeloid leukemia have supe- rior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered显示文摘 | BYRD JC DODGE RK CARROLL A | 1999 | J Clin Oncol1999，17，12： | 1 |
| 17 | Patients with t(8;21) (q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered 显示文摘 | Byrd JC Dodge PK Carroll A | 1999 | J Clin Oncol1999，17，： | 1 |
| 18 | Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease 显示文摘 | Dodge JC Clarke J Song A Bu J Yang W Taksir TV | 2005 | Proc Natl Acad Sci USA2005，102，17： | 1 |
| 19 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patienls with de novo acute myetoid leukemia: results from Cancer and Leukemia Group B (CALGB 846 l)显示文摘 | Byrd JC K Mr6zek Dodge RK | 2002 | Blood2002，100，： | 1 |
| 20 | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) 显示文摘 | Byrd JC Mr6zek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员